Cancer Channel
Related Channels

Pazopanib and Thyroid Cancer

Approved only for use in adults, pazopanib (Votrient®) is prescribed to help treat advanced renal cell carcinoma, the most common type of kidney cancer. It is also approved to treat advanced soft tissue sarcoma, a type of cancer of soft tissues, such as muscle, blood vessels, nerves, and fat. However, there are times when a healthcare provider may prescribe this drug for an off-label (unapproved) use. For example, pazopanib can be prescribed off-label to treat thyroid cancer.
This medicine works by blocking an enzyme in the body that tells cancer cells to grow and divide. By blocking this enzyme, pazopanib can help slow down the growth of cancer cells.
(For more details on using this drug for thyroid cancer, click What Is Pazopanib Used For?. This article provides more information on how this medicine works, whether it is safe for use in older adults, and other off-label uses.)
The Zen of Cancer Caregiving - Recharge Your Batteries!
Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2019 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.